99 related articles for article (PubMed ID: 35674221)
1. Corrigendum to: iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Mol Oncol; 2022 Jul; 16(13):2607-2608. PubMed ID: 35674221
[No Abstract] [Full Text] [Related]
2. iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Lin D; Zhang H; Liu R; Deng T; Ning T; Bai M; Yang Y; Zhu K; Wang J; Duan J; Ge S; Sun B; Ying G; Ba Y
Mol Oncol; 2021 Dec; 15(12):3430-3446. PubMed ID: 34213835
[TBL] [Abstract][Full Text] [Related]
3. Exosomal CD44 Transmits Lymph Node Metastatic Capacity Between Gastric Cancer Cells
Wang M; Yu W; Cao X; Gu H; Huang J; Wu C; Wang L; Sha X; Shen B; Wang T; Yao Y; Zhu W; Huang F
Front Oncol; 2022; 12():860175. PubMed ID: 35359362
[TBL] [Abstract][Full Text] [Related]
4. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
5. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
6. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.
Hui B; Lu C; Wang J; Xu Y; Yang Y; Ji H; Li X; Xu L; Wang J; Tang W; Wang K; Gu Y
J Cell Physiol; 2022 Jan; 237(1):911-933. PubMed ID: 34463962
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes.
Han S; Li G; Jia M; Zhao Y; He C; Huang M; Jiang L; Wu M; Yang J; Ji X; Liu X; Chen C; Chu X
Front Mol Biosci; 2021; 8():743013. PubMed ID: 34616773
[No Abstract] [Full Text] [Related]
8. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Wang L; Li C; Song Y; Yan Z
Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
[TBL] [Abstract][Full Text] [Related]
9. Poly-ion complex micelles effectively deliver CoA-conjugated CPT1A inhibitors to modulate lipid metabolism in brain cells.
Paraiso WKD; Garcia-Chica J; Ariza X; Zagmutt S; Fukushima S; Garcia J; Mochida Y; Serra D; Herrero L; Kinoh H; Casals N; Kataoka K; Rodríguez-Rodríguez R; Quader S
Biomater Sci; 2021 Oct; 9(21):7076-7091. PubMed ID: 34397074
[TBL] [Abstract][Full Text] [Related]
10. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH
Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871
[TBL] [Abstract][Full Text] [Related]
11. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.
Zhou W; Zhou Y; Chen X; Ning T; Chen H; Guo Q; Zhang Y; Liu P; Zhang Y; Li C; Chu Y; Sun T; Jiang C
Biomaterials; 2021 Jan; 268():120546. PubMed ID: 33253966
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells.
Montazami N; Kheir Andish M; Majidi J; Yousefi M; Yousefi B; Mohamadnejad L; Shanebandi D; Estiar MA; Khaze V; Mansoori B; Baghbani E; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):98-103. PubMed ID: 26025411
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
[TBL] [Abstract][Full Text] [Related]
15. Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation.
Hao F; Tian M; Zhang X; Jin X; Jiang Y; Sun X; Wang Y; Peng P; Liu J; Xia C; Feng Y; Wei M
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035164
[TBL] [Abstract][Full Text] [Related]
16. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Peng S; Chen D; Cai J; Yuan Z; Huang B; Li Y; Wang H; Luo Q; Kuang Y; Liang W; Liu Z; Wang Q; Cui Y; Wang H; Liu X
Mol Oncol; 2021 May; 15(5):1391-1411. PubMed ID: 33528867
[TBL] [Abstract][Full Text] [Related]
17. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.
Egorova A; Selutin A; Maretina M; Selkov S; Baranov V; Kiselev A
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33050526
[TBL] [Abstract][Full Text] [Related]
18. ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.
Guo C; Ma J; Deng G; Qu Y; Yin L; Li Y; Han Y; Cai C; Shen H; Zeng S
J Cancer; 2017; 8(17):3555-3566. PubMed ID: 29151941
[No Abstract] [Full Text] [Related]
19. iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer.
Lo JH; Hao L; Muzumdar MD; Raghavan S; Kwon EJ; Pulver EM; Hsu F; Aguirre AJ; Wolpin BM; Fuchs CS; Hahn WC; Jacks T; Bhatia SN
Mol Cancer Ther; 2018 Nov; 17(11):2377-2388. PubMed ID: 30097486
[TBL] [Abstract][Full Text] [Related]
20. Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells.
Pullan J; Dailey K; Bhallamudi S; Feng L; Alhalhooly L; Froberg J; Osborn J; Sarkar K; Molden T; Sathish V; Choi Y; Brooks A; Mallik S
ACS Appl Bio Mater; 2022 May; 5(5):2163-2175. PubMed ID: 35417133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
